Loss of LGR5 through plasticity or gene ablation is associated with therapy resistance and enhanced MET-STAT3 signaling in colorectal cancer cells
T. A. Posey, J. Jacob, A. N. Parkhurst, S. Subramanian, L. E. Francisco, Z. Liang, K. S. Carmon
This study shows that loss of LGR5 in colorectal cancer cells through plasticity or gene ablation activates MET-STAT3 signaling, leading to therapy resistance and suggesting new treatment strategies targeting plasticity.
bioRxiv · Mar 1, 2022 · PreprintCancer Biology